NeoTX is a specialty biopharmaceutical company, with a focus on research and development in oncology immunotherapy. With a strong research and development team, our strategy is to build a patented, proprietary and unique product pipeline to capitalize on technologies that NeoTX is developing independently and through collaborative partnerships and license agreements.
InterX, Inc. is a biotechnology startup revolutionizing biomolecular computation. their goal is to achieve robust and accurate prediction of molecular and ensemble properties of biological systems. Led by Nobel Prize-winning scientists, InterX is creating tools for pharmaceutical ligand design, material science, and biochemistry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.